Literature DB >> 23698139

Mexican pharmacies: benefits and risks for border residents in the United States of America and Mexico.

Núria Homedes1, Antonio Ugalde.   

Abstract

OBJECTIVE: To determine the benefits and risks of using Mexican pharmacies by better understanding the sociodemographics and medication needs of pharmacy clients in Ciudad Juárez; and to ascertain the role and expertise of pharmacy clerks and their impact on medication use.
METHODS: Cross-sectional study of a convenience sample of 32 pharmacies in Ciudad Juárez conducted in August 2007-January 2008. Medical professionals interviewed 230 pharmacy clients and 25 pharmacy owners and clerks, and observed 152 clerk-client interactions. The cost of the most frequently-purchased medications was compared with pricing at pharmacies in El Paso, Texas, United States.
RESULTS: Of the 311 medications purchased, the most frequent were: antibiotics (54), analgesics (49), fixed drug combinations (29), and blood pressure medications (26). Only 38% were purchased with a prescription; 62% of the prescription drugs bought without a prescription were self-prescribed. Many products purchased were of limited therapeutic value, and others could be harmful when used inappropriately. Pharmacy clerks were poorly trained and did not offer appropriate information on drug use; contraindications were never discussed. Contrary to popular perception, some generic drugs were cheaper in the United States than in Mexico. Conflicts of interest were identified that could be leading to over-medication.
CONCLUSIONS: While the risks are evident, some uninsured, chronically-ill United States residents may benefit from access to medications previously recommended by a physician, without obtaining a new prescription. The authors suggest five steps for reducing the risks and improving pharmaceutical utilization in the border area.

Mesh:

Substances:

Year:  2013        PMID: 23698139     DOI: 10.1590/s1020-49892013000300006

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  3 in total

1.  Co-occurrence of alcohol, drug use, DSM-5 alcohol use disorder, and symptoms of drug use disorder on both sides of the U.S.-Mexico border.

Authors:  Guilherme Borges; Sarah Zemore; Ricardo Orozco; Cheryl J Cherpitel; Yu Ye; Jason Bond; Jane Carlisle Maxwell; Lynn Wallisch
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

2.  Cultural Sensitivity and Global Pharmacy Engagement in Latin America: Argentina, Brazil, Ecuador, Guatemala, and Mexico.

Authors:  Sally L Haack; Inbal Mazar; Erin M Carter; Joyce Addo-Atuah; Melody Ryan; Laura Leticia Salazar Preciado; Luis Renee González Lucano; Aliz Lorena Barrera Ralda
Journal:  Am J Pharm Educ       Date:  2019-05       Impact factor: 2.047

3.  Understanding differences in prescription drug misuse between two Texas border communities.

Authors:  Priscilla Martinez; Sarah E Zemore; Miguel Pinedo; Guilherme Borges; Ricardo Orozco; Cheryl Cherpitel
Journal:  Ethn Health       Date:  2019-05-22       Impact factor: 2.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.